Download PDF
Z Gastroenterol 2002; 40(6): 475-477
DOI: 10.1055/s-2002-32125
Kommentiertes Referat
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York

Kontrainflammatorische Wirkungen von Interleukin-10 bei Patienten mit M. Crohn: viele Fragen, viele Möglichkeiten

Anti-inflammatory properties of interleukin-10 in human Crohn‘s disease: much to learn, much to exploreA. Stallmach, C. Schmidt, T. Marth
  • 1Innere Medizin II, Universitätskliniken des Saarlandes
Further Information

Publication History

Publication Date:
10 June 2002 (online)

Also available at
    Permissions and Reprints

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. Lindsay JO, Ciesielski CJ, Scheinin T, Hodgson HJ, Brennan FM. J Immunol 2001; 166: 7625-7633

Treatment of Crohn‘s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Tilg H, van Montfrans C, van Den Ende A, Kaser A, van Deventer SJ, Schreiber S, Gregor M, Ludwiczek O, Rutgeerts P, Gasche C, Koningsberger JC, Abreu L, Kuhn I, Cohard M, LeBeaut A, Grint P, Weiss G. Gut 2002; 50: 191-195

Interleukin 10 (Tenovil®) in the prevention of postoperative recurrence of Crohn‘s disease. Colombel JF, Rutgeerts P, Malchow H, Jacyna M, Nielsen OH, Rask-Madsen J, Van Deventer S, Ferguson A, Desreumaux P, Forbes A, Geboes K, Melani L, Cohard M. Gut 2001; 49: 42-46

Prof. Dr. med. A. Stallmach

Innere Medizin II, Universitätskliniken des Saarlandes

66421 Homburg/Saar